139 related articles for article (PubMed ID: 29928391)
1. CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer.
Xia E; Wang Y; Bhandari A; Niu J; Yang F; Yao Z; Wang O
Oncol Lett; 2018 Jul; 16(1):105-112. PubMed ID: 29928391
[TBL] [Abstract][Full Text] [Related]
2. CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27.
Li H; Guan H; Guo Y; Liang W; Liu L; He X; Ke W; Cao X; Xiao H; Li Y
Cell Biosci; 2018; 8():57. PubMed ID: 30450190
[TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer.
Sassa M; Hayashi Y; Watanabe R; Kikumori T; Imai T; Kurebayashi J; Kiuchi T; Murata Y
Thyroid; 2011 May; 21(5):511-7. PubMed ID: 21449767
[TBL] [Abstract][Full Text] [Related]
4. CITED1 contributes to the progression of papillary thyroid carcinoma via the Wnt/β-catenin signaling pathway.
Wang Y; Huang H; Hu F; Li J; Zhang L; Pang H
Onco Targets Ther; 2019; 12():6769-6777. PubMed ID: 31686836
[TBL] [Abstract][Full Text] [Related]
5. Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer.
Wang Y; Jin Y; Bhandari A; Yao Z; Yang F; Pan Y; Zheng Z; Lv S; Wang O
Onco Targets Ther; 2018; 11():37-46. PubMed ID: 29317832
[TBL] [Abstract][Full Text] [Related]
6. NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT.
Hao RT; Zheng C; Wu CY; Xia EJ; Zhou XF; Quan RD; Zhang XH
Cancer Manag Res; 2019; 11():2565-2578. PubMed ID: 31114323
[TBL] [Abstract][Full Text] [Related]
7. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
[TBL] [Abstract][Full Text] [Related]
8. Proto-oncogene RTL4 promotes tumorigenesis and invasiveness of papillary thyroid cancer.
Kong L; Bhandari A; Zhang X; Wang O
Am J Transl Res; 2020; 12(6):3023-3032. PubMed ID: 32655827
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.
Wen DY; Pan DH; Lin P; Mo QY; Wei YP; Luo YH; Chen G; He Y; Chen JQ; Yang H
Mol Med Rep; 2018 Sep; 18(3):2631-2642. PubMed ID: 30015845
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis.
Xia S; Wang C; Postma EL; Yang Y; Ni X; Zhan W
Onco Targets Ther; 2017; 10():1743-1755. PubMed ID: 28367057
[TBL] [Abstract][Full Text] [Related]
11. CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study.
Prasad ML; Pellegata NS; Kloos RT; Barbacioru C; Huang Y; de la Chapelle A
Thyroid; 2004 Mar; 14(3):169-75. PubMed ID: 15072698
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
13. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer.
Zhou X; Xia E; Bhandari A; Zheng C; Xiang J; Guan Y; Zhang X
Biochem Biophys Res Commun; 2018 Sep; 503(1):257-263. PubMed ID: 29885843
[TBL] [Abstract][Full Text] [Related]
14. Preparation and SPECT/CT Imaging of
Li J; Zhang L; Li W; Lei C; Cao Y; Wang Y; Wang Z; Pang H
Onco Targets Ther; 2020; 13():487-496. PubMed ID: 32021292
[TBL] [Abstract][Full Text] [Related]
15. Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression.
Chen Y; Quan R; Bhandari A; Chen Z; Guan Y; Xiang J; You J; Teng L
Am J Transl Res; 2019; 11(3):1760-1770. PubMed ID: 30972199
[TBL] [Abstract][Full Text] [Related]
16. GABRB2 plays an important role in the lymph node metastasis of papillary thyroid cancer.
Jin Y; Jin W; Zheng Z; Chen E; Wang Q; Wang Y; Wang O; Zhang X
Biochem Biophys Res Commun; 2017 Oct; 492(3):323-330. PubMed ID: 28859983
[TBL] [Abstract][Full Text] [Related]
17. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
18. E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.
Sun J; Shi R; Zhao S; Li X; Lu S; Bu H; Ma X; Su C
J Exp Clin Cancer Res; 2017 Mar; 36(1):40. PubMed ID: 28270228
[TBL] [Abstract][Full Text] [Related]
19. Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression.
Zheng C; Quan R; Xia EJ; Bhandari A; Zhang X
Oncol Lett; 2019 Sep; 18(3):3227-3235. PubMed ID: 31452800
[TBL] [Abstract][Full Text] [Related]
20. MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer.
Dong SY; Chen H; Lin LZ; Jin L; Chen DX; Wang OC; Ye ZQ
Cancer Manag Res; 2020; 12():12557-12567. PubMed ID: 33324100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
